SH3-PX-BAR类蛋白在钙化性主动脉瓣狭窄发生发展中的作用机制研究
批准号:
81970325
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
陈茂
依托单位:
学科分类:
心脏瓣膜疾病和心包疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
陈茂
中文摘要
钙化性主动脉瓣狭窄(CAVS)是一种退行性变的瓣膜疾病,早期表现为瓣膜增厚,基质分泌过多,其中机制仍不清。本课题旨在探索参与CAVS发生发展的重要蛋白分子。Sorting nexin蛋白是内小体功能蛋白,负责蛋白转运和囊泡运输。我们采用蛋白质谱分析了钙化和正常人瓣膜组织蛋白,发现Sorting nexin蛋白成员中,仅同属SH3-PX-BAR类蛋白的SNX9,SNX18和SNX33在人钙化瓣膜中表达显著下调。SNX18敲除小鼠的主动脉瓣膜比正常小鼠的基质胶原纤维明显增多。因此我们假设以SNX18为代表的SH3-PX-BAR蛋白在瓣膜钙化中发挥了重要作用。我们将借助基因敲除小鼠、体外培养人和小鼠瓣膜间质细胞进一步明确瓣膜间质细胞中SH3-PX-BAR蛋白的功能和细胞表型,从囊泡重塑等方向解释其调控机制。本课题将揭示该退行性变疾病的新的发病机制。
英文摘要
Calcific aortic valve stenosis (CAVS) is a degenerative valvular disease, with valve incrassation and hyperfibrosis, but its mechanism still needs to be clarified. Sorting nexin family proteins are the functional proteins localized at endosomes, in charge of the protein trafficking and vesicular transport. Our project is aim to find out the key proteins in the progression of CAVS. We have found that the expression of the SH3-PX-BAR proteins including SNX9, SNX18 and SNX33 were heavily downregulated in the human calcific valves, compared with the normal ones. And the aortic valves of SNX18 knockout mice got thicker than those wildtypes. We hypothesis that the SH3-PX-BAR proteins may play an important role in the progression of CAVS. Next, we will verify the functional phenotype of these proteins, and explain the exact mechanism. This project will uncover another important factors in the disease.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
10.1097/cm9.0000000000001882
发表时间:
2021-11-19
期刊:
Chinese medical journal
影响因子:
6.1
作者:
[Li YM, Xiong TY, Xu K, Fang ZF, Jiang L, Jin J, He SH, Yang YN, He JJ, Jia YH, Zhang Y, Peng Y, Feng Y, Chen M]
通讯作者:
Chen M
DOI:
10.1096/fj.202300201rr
发表时间:
2023
期刊:
The FASEB Journal
影响因子:
作者:
[Yan Wang, Zhen‐Gang Zhao, Zheng Chai, Jian‐Cheng Fang, Mao Chen]
通讯作者:
Mao Chen
DOI:
10.1016/j.jcin.2020.04.019
发表时间:
2020
期刊:
JACC: Cardiovascular Interventions
影响因子:
作者:
[Yuanweixiang Ou, Yijun Yao, Jingjing He, Yanbiao Liao, Zijie Wang, Xuan Zhou, Mingxia Zheng, Wei Meng, Yuan Feng, Mao Chen]
通讯作者:
Mao Chen
Mitophagy: A Potential Target for Pressure Overload-Induced Cardiac Remodelling.
线粒体自噬:压力过载引起的心脏重塑的潜在目标
DOI:
10.1155/2022/2849985
发表时间:
2022
期刊:
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
影响因子:
--
作者:
[Shao, Ruochen, Li, Junli, Qu, Tianyi, Liao, Yanbiao, Chen, Mao]
通讯作者:
Chen, Mao
Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves
0 型二尖瓣、1 型二尖瓣和三尖瓣主动脉瓣患者经导管主动脉瓣置换术治疗主动脉瓣狭窄后的结果
DOI:
10.1161/circinterventions.123.013083
发表时间:
2023
期刊:
Circulation: Cardiovascular Interventions
影响因子:
--
作者:
[Jing, T. Xiong, Yijun Yao, Yong Peng, Jiafu Wei, Zhen, Guo Chen, Y. Ou, Qi Liu, Xi Wang, Zhongkai Zhu, Hao, Kaiyu Jia, D. Mylotte, Nicolo Piazza, Bernard Prendergast, Yuan Feng, Mao Chen]
通讯作者:
Mao Chen
共 23 条
基于巨噬细胞源性破骨样细胞铁死亡探讨Hmox-1在主动脉瓣钙化进展中的作用及机制
-
批准号:82170375
-
项目类别:面上项目
-
资助金额:65万元
-
批准年份:2021
-
负责人:陈茂
-
依托单位:
Annexin-V-SDF-1融合蛋白促进梗死心脏修复的机制研究
-
批准号:81370219
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:陈茂
-
依托单位:
SDF/CXCR4耦合在骨髓间充质细胞向心肌细胞转化过程中的作用
-
批准号:30600607
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:陈茂
-
依托单位:
国内基金
海外基金